["Asymptomatic WPW" : Is treatment necessary?]
„Asymptomatisches WPW“ : Bedarf es einer Therapie?
Catheter ablation
Risk stratification
Sudden cardiac death
Ventricual prexcitation, asymptomatic
Ventricular pre-excitation
WPW syndrome
Journal
Herzschrittmachertherapie & Elektrophysiologie
ISSN: 1435-1544
Titre abrégé: Herzschrittmacherther Elektrophysiol
Pays: Germany
ID NLM: 9425873
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
30
12
2022
accepted:
30
01
2023
medline:
1
6
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
ppublish
Résumé
The term "asymptomatic WPW" (Wolff-Parkinson-White) is often used as a synonym for ventricular pre-excitation of the WPW type due to an accessory pathway characterized by a short PR interval and a delta wave on the electrocardiogram (ECG) without the clinical occurrence of paroxysmal tachycardia. Asymptomatic WPW is often diagnosed in young and otherwise healthy people. There is a small associated risk of sudden cardiac death due to rapid antegrade conduction over the accessory pathway during atrial fibrillation. This paper highlights aspects of noninvasive and invasive risk stratification, therapy by catheter ablation, and the ongoing risk-benefit discussion in asymptomatic WPW. Der Begriff „asymptomatisches WPW“ wird als Synonym für eine ventrikuläre Präexzitation vom WPW (Wolff-Parkinson-White) Typ aufgrund einer akzessorischen Leitungsbahn verwendet, die sich im Elektrokardiogramm (EKG) im Sinusrhythmus durch eine kurze PQ-Zeit mit Deltawelle manifestiert, ohne dass es bei den Betroffenen zum Auftreten von paroxysmalen Tachykardien kommt. Häufig wird das asymptomatische WPW als Zufallsbefund bei jüngeren Personen ohne sonstige kardiale Auffälligkeiten diagnostiziert. Es besteht ein geringes Risiko des plötzlichen Herztods durch eine schnelle Überleitung auf die Herzkammern über die akzessorische Bahn bei Vorhofflimmern. In diesem Artikel werden verschiedene Aspekte zur nichtinvasiven und invasiven Risikostratifizierung, zur Therapie durch Katheterablation und zur individuellen Risk-Benefit-Diskussion bei asymptomatischem WPW beleuchtet.
Autres résumés
Type: Publisher
(ger)
Der Begriff „asymptomatisches WPW“ wird als Synonym für eine ventrikuläre Präexzitation vom WPW (Wolff-Parkinson-White) Typ aufgrund einer akzessorischen Leitungsbahn verwendet, die sich im Elektrokardiogramm (EKG) im Sinusrhythmus durch eine kurze PQ-Zeit mit Deltawelle manifestiert, ohne dass es bei den Betroffenen zum Auftreten von paroxysmalen Tachykardien kommt. Häufig wird das asymptomatische WPW als Zufallsbefund bei jüngeren Personen ohne sonstige kardiale Auffälligkeiten diagnostiziert. Es besteht ein geringes Risiko des plötzlichen Herztods durch eine schnelle Überleitung auf die Herzkammern über die akzessorische Bahn bei Vorhofflimmern. In diesem Artikel werden verschiedene Aspekte zur nichtinvasiven und invasiven Risikostratifizierung, zur Therapie durch Katheterablation und zur individuellen Risk-Benefit-Diskussion bei asymptomatischem WPW beleuchtet.
Identifiants
pubmed: 36939928
doi: 10.1007/s00399-023-00930-x
pii: 10.1007/s00399-023-00930-x
doi:
Types de publication
English Abstract
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
114-121Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Références
Wolff L, Parkinson J, White PD (2006) Bundle-branch block with short P‑R interval in healthy young people prone to paroxysmal tachycardia. 1930. Ann Noninvasive Electrocardiol 11(4):340–353
doi: 10.1111/j.1542-474X.2006.00127.x
pubmed: 17040283
pmcid: 6932258
Holzmann M (1932) Über Elektrokardiogramme mit verkürzter Vorhofkammer – Distanz und positive P‑Zacken. Z Klin Med 121:404
Cohen MI et al (2012) PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the pediatric and congenital electrophysiology society (PACES) and the heart rhythm society (HRS). Endorsed by the governing bodies of PACES, HRS, the American college of cardiology foundation (ACCF), the American heart association (AHA), the American academy of pediatrics (AAP), and the Canadian heart rhythm society (CHRS). Heart Rhythm 9(6):1006–1024
doi: 10.1016/j.hrthm.2012.03.050
pubmed: 22579340
Emmel M, Balaji S, Sreeram N (2004) Ventricular preexcitation associated with dilated cardiomyopathy: a causal relationship? Cardiol Young 14(6):594–599
doi: 10.1017/S1047951104006031
pubmed: 15679994
Montoya PT et al (1991) Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J 12(2):144–150
doi: 10.1093/oxfordjournals.eurheartj.a059860
pubmed: 2044547
Timmermans C et al (1995) Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol 76(7):492–494
doi: 10.1016/S0002-9149(99)80136-2
pubmed: 7653450
Munger TM et al (1993) A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953–1989. Circulation 87(3):866–873
doi: 10.1161/01.CIR.87.3.866
pubmed: 8443907
Santinelli V et al (2009) The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children. J Am Coll Cardiol 53(3):275–280
doi: 10.1016/j.jacc.2008.09.037
pubmed: 19147045
Dreifus LS et al (1971) Ventricular fibrillation. A possible mechanism of sudden death in patients and Wolff-Parkinson-White syndrome. Circulation 43(4):520–527
doi: 10.1161/01.CIR.43.4.520
pubmed: 5573385
Fukatani M et al (1990) Prediction of a fatal atrial fibrillation in patients with asymptomatic Wolff-Parkinson-White pattern. Jpn Circ J 54(10):1331–1339
doi: 10.1253/jcj.54.10_1331
pubmed: 2277412
Pietersen AH, Andersen ED, Sandøe E (1992) Atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol 70(5):38a–43a
doi: 10.1016/0002-9149(92)91076-G
pubmed: 1509997
Rao AL et al (2014) Evaluation and management of Wolff-Parkinson-White in athletes. Sports Health 6(4):326–332
doi: 10.1177/1941738113509059
pubmed: 24982705
pmcid: 4065555
Arnar DO et al (2019) Management of asymptomatic arrhythmias: a European heart rhythm association (EHRA) consensus document, endorsed by the heart failure association (HFA), heart rhythm society (HRS), asia pacific heart rhythm society (APHRS), cardiac arrhythmia society of southern africa (CASSA), and latin america heart rhythm society (LAHRS). Europace 21(6):844–845
doi: 10.1093/europace/euz046
pubmed: 30882141
Pappone C et al (2003) Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol 41(2):239–244
doi: 10.1016/S0735-1097(02)02706-7
pubmed: 12535816
Etheridge SP et al (2018) Life-threatening event risk in children with Wolff-Parkinson-White syndrome: a multicenter international study. JACC Clin Electrophysiol 4(4):433–444
doi: 10.1016/j.jacep.2017.10.009
pubmed: 30067481
Page RL et al (2016) 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol 67(13):e27–e115
doi: 10.1016/j.jacc.2015.08.856
pubmed: 26409259
Zipes DP et al (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American heart association and American college of cardiology. J Am Coll Cardiol 66(21):2412–2423
doi: 10.1016/j.jacc.2015.09.041
pubmed: 26542670
Brembilla-Perrot B, Girerd N, Sellal JM (2018) Unresolved questions associated with the management of ventricular preexcitation syndrome. Pacing Clin Electrophysiol 41(7):839–844
doi: 10.1111/pace.13367
pubmed: 29754436
Pelliccia A et al (2005) Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European society of cardiology. Eur Heart J 26(14):1422–1445
doi: 10.1093/eurheartj/ehi325
pubmed: 15923204
Vidaillet HJ Jr. et al (1987) Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). N Engl J Med 317(2):65–69
doi: 10.1056/NEJM198707093170201
pubmed: 3587328
Daubert C et al (1988) Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome. Pacing Clin Electrophysiol 11(8):1130–1138
doi: 10.1111/j.1540-8159.1988.tb03964.x
pubmed: 2459665
Czosek RJ et al (2011) Noninvasive risk stratification techniques in pediatric patients with ventricular preexcitation. Pacing Clin Electrophysiol 34(5):555–562
doi: 10.1111/j.1540-8159.2010.03011.x
pubmed: 21609337
Dalili M et al (2014) Exercise testing in children with Wolff-Parkinson-White syndrome: what is its value? Pediatr Cardiol 35(7):1142–1146
doi: 10.1007/s00246-014-0907-5
pubmed: 24728424
Escudero CA et al (2020) Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: a multicenter study of WPW in children. Heart Rhythm 17(10):1729–1737
doi: 10.1016/j.hrthm.2020.05.035
pubmed: 32497761
Brugada J et al (2020) 2019 ESC guidelines for the management of patients with supraventricular tachycardia. The task force for the management of patients with supraventricular tachycardia of the European society of cardiology (ESC). Eur Heart J 41(5):655–720
doi: 10.1093/eurheartj/ehz467
pubmed: 31504425
Klein GJ, Gulamhusein SS (1983) Intermittent preexcitation in the Wolff-Parkinson-White syndrome. Am J Cardiol 52(3):292–296
doi: 10.1016/0002-9149(83)90125-X
pubmed: 6869275
Telishevska M et al (2019) Catheter ablation in ASymptomatic PEDiatric patients with ventricular preexcitation: results from the multicenter “CASPED” study. Clin Res Cardiol 108(6):683–690
doi: 10.1007/s00392-018-1397-x
pubmed: 30519781
Obeyesekere MN, Klein GJ (2017) Application of the 2015 ACC/AHA/HRS guidelines for risk stratification for sudden death in adult patients with asymptomatic pre-excitation. J Cardiovasc Electrophysiol 28(7):841–848
doi: 10.1111/jce.13245
pubmed: 28470984
Garg J et al (2017) Catheter ablation of accessory pathway: 14-year trends in utilization and complications in adults in the United States. Int J Cardiol 248:196–200
doi: 10.1016/j.ijcard.2017.06.115
pubmed: 28712558
Mao J et al (2015) Catheter ablation of accessory pathways near the coronary sinus: value of defining coronary arterial anatomy. Heart Rhythm 12(3):508–514
doi: 10.1016/j.hrthm.2014.11.035
pubmed: 25485779
Pappone C et al (2003) A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med 349(19):1803–1811
doi: 10.1056/NEJMoa035345
pubmed: 14602878
Wellens HJ (2005) Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram. Circulation 112(14):2201–2207 (discussion 2216)
doi: 10.1161/CIRCULATIONAHA.104.483321
pubmed: 16203931
Pappone C et al (2014) Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients. Circulation 130(10):811–819
doi: 10.1161/CIRCULATIONAHA.114.011154
pubmed: 25052405
Schmitt C, Deisenhofer I, Zrenner B (2006) Catheter ablation of cardiac arrhythmias. A practical approach. Steinkopff Verlag, Darmstadt
doi: 10.1007/3-7985-1576-X